BARCELONA, Spain--(BUSINESS WIRE)--The Cochrane Library recently published a review of chondroitin sulfate that confirms the efficacy and safety of this drug in the treatment of osteoarthritis (OA). The conclusions remark that the patients treated with chondroitin sulfate achieved statistically significantly and clinically meaningful better pain and functional capacity scores. This drug also has improved safety standards.
“These are highly relevant results that, from my point of view, should put an end to the controversy on the efficacy and safety of chondroitin sulfate. At Bioiberica we have been working for more than 10 years on this product, whose efficacy has been scientifically and clinically proved”, declared Dr. Josep Vergés, clinical pharmacologist and medical and scientific director of Bioiberica.
Help employers find you! Check out all the jobs and post your resume.
“These are highly relevant results that, from my point of view, should put an end to the controversy on the efficacy and safety of chondroitin sulfate. At Bioiberica we have been working for more than 10 years on this product, whose efficacy has been scientifically and clinically proved”, declared Dr. Josep Vergés, clinical pharmacologist and medical and scientific director of Bioiberica.
Help employers find you! Check out all the jobs and post your resume.
